CSI Market
Sign In | Register

Merck and Co Inc (MRK) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MRK Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Merck and Co Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-5,575.00
Depreciation & amortization1,180.00
Amortization of Other Assets1,915.00
Minority interests0.00
Asset Impairment Charges346.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
Research and Development in Process0.00
Sales of business0.00
Share-based Compensation483.00
Income (Loss) from Equity Method Investments0.00
Gain (Loss) on Contract Termination-75.00
Gain Loss Related To Litigation Settlement-
Impairment Of Intangible Assets Excluding Goodwill-
Charge For License Options Related To Collaboration-
Goodwill And Intangible Asset Impairment-
Equity Securities Fv Ni Gain Loss-168.00
Research And Development Asset Acquisition Other Than Through Business Combination Write Off Asset Acquisition Two-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Income taxes0.00
Losses/ -gains on investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable, Trade0.00
Increase (Decrease) in Accrued Liabilities0.00
Working capital Items0.00
Employee severance & pension0.00
Other Working Capital1,190.00
Other Noncash Income (Expense)61.00
Other net-5.00
Payments for (Proceeds from) Other Operating Activities9,768.00
Discontinued operations0.00
Net Cash flow from Operating Activities9,288.00
Investing Activities
Capital Expenditures-1,884.00
Sale of Capital Items132.00
Short-term investments liq.0.00
Payments to Acquire Marketable Securities0.00
Payments for (Proceeds from) Hedge, Investing Activities0.00
Merger Net Of Cash Acquired-
Amount Received From Partner By Company For Exercise Of Asset Option-
Proceeds From Divestiture Of Business Two Net Of Cash Divested-
Payments To Acquire Business Four Net Of Cash Acquired-
Payments To Acquire Business Five Net Of Cash Acquired-
Payments To Acquire Business Four-
Proceeds From Sale Of Equity Securities Fv Ni-
Purchases of other investments0.00
Noncontrolling interest0.00
Proceeds from Investments0.00
Payments to Acquire Investments781.00
Purchases of non-current assets0.00
Payments to Acquire Businesses, Net of Cash Acquired-14,621.00
Investment in affiliate0.00
Proceeds from Divestiture of Businesses, Net of Cash Divested0.00
Proceeds from sale of assets0.00
Notes receivable0.00
Payments for (Proceeds from) Other Investing Activities-88.00
Other Net-132.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-15,812.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings5,956.00
Long-term debt - repayments-1,145.00
Noncontrolling interest0.00
Issuances / -repurchases of Comm. Stock-1,431.00
Exercise of stock options0.00
Issuances / -repurchases of Pref. Stock0.00
Discontinued Operations0.00
Other financing activities net-350.00
Other net0.00
Other Dividends Paid-
Disposal Group Including Discontinued Operations Distribution Received-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents14,690.00
Disposal Group Incl Discontinued Operations Distribution Received-
Dividends paid to minority interests0.00
Dividends paid-4,249.00
Net Cash Flow from Financing Activities-1,219.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7,536.00
Total Cash Flow-7,799.00
4 historic quarters locked

Sign in to unlock the full Merck and Co Inc cash flow history.

Sign In Create Free Account

About Merck and Co Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 7, 2026
  • Source: mrk-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000310158-26-000212

Figures are derived from filed reports and may be restated. Historical data is subject to revision.